Insights

Innovative Platform Engine Biosciences leverages a proprietary network biomedicine platform combining high-throughput experimentation with artificial intelligence, enabling faster and more cost-effective drug discovery which presents opportunities to collaborate with biotech firms seeking advanced R&D solutions.

Expanding Partnerships Recent collaborations, such as the partnership with Singapore's Experimental Drug Development Centre, highlight the company's active engagement in international drug development networks, aligning with pharmaceutical companies interested in expanding their innovation collaborations.

Strong Funding Backing With recent Series A financing exceeding 27 million dollars and notable investor backing like Polaris Partners, Engine Biosciences is financially well-positioned to scale its technological offerings and pursue strategic sales opportunities.

Growth in Biotech Sector Operating within a competitive biotech environment with companies of similar size and revenue, Engine Biosciences has opportunities to target research institutions and biotech firms requiring advanced network biology and AI-driven drug discovery capabilities.

Global Presence Based in San Francisco and Asia, the company's geographic footprint facilitates access to diverse markets and enables tailored solutions for regional biotech and pharma clients seeking innovative platform-based research tools.

Engine Biosciences Tech Stack

Engine Biosciences uses 8 technology products and services including Open Graph, oEmbed, Google Fonts API, and more. Explore Engine Biosciences's tech stack below.

  • Open Graph
    Content Management System
  • oEmbed
    Dev Tools
  • Google Fonts API
    Font Scripts
  • Font Awesome
    Font Scripts
  • Isotope
    Javascript Libraries
  • WP Engine
    Platform As A Service
  • Animate.css
    UI Frameworks
  • Nginx
    Web Servers

Media & News

Engine Biosciences's Email Address Formats

Engine Biosciences uses at least 1 format(s):
Engine Biosciences Email FormatsExamplePercentage
First.Last@enginebio.comJohn.Doe@enginebio.com
78%
FirstLast@enginebio.comJohnDoe@enginebio.com
18%
Last@enginebio.comDoe@enginebio.com
3%
FirstMiddle.Last@enginebio.comJohnMichael.Doe@enginebio.com
1%

Frequently Asked Questions

What is Engine Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Engine Biosciences's official website is enginebio.com and has social profiles on LinkedInCrunchbase.

What is Engine Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Engine Biosciences's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Engine Biosciences have currently?

Minus sign iconPlus sign icon
As of December 2025, Engine Biosciences has approximately 32 employees across 2 continents, including AsiaNorth America. Key team members include Cio & Sr. Advisor: Y. T. י. ט.Chief Information Officer & Sr Advisor: Y. T.Co-Founder And Ceo: J. L.. Explore Engine Biosciences's employee directory with LeadIQ.

What industry does Engine Biosciences belong to?

Minus sign iconPlus sign icon
Engine Biosciences operates in the Biotechnology Research industry.

What technology does Engine Biosciences use?

Minus sign iconPlus sign icon
Engine Biosciences's tech stack includes Open GraphoEmbedGoogle Fonts APIFont AwesomeIsotopeWP EngineAnimate.cssNginx.

What is Engine Biosciences's email format?

Minus sign iconPlus sign icon
Engine Biosciences's email format typically follows the pattern of First.Last@enginebio.com. Find more Engine Biosciences email formats with LeadIQ.

How much funding has Engine Biosciences raised to date?

Minus sign iconPlus sign icon
As of December 2025, Engine Biosciences has raised $27M in funding. The last funding round occurred on Oct 31, 2023 for $27M.

Engine Biosciences

Biotechnology ResearchCentral Region, Singapore11-50 Employees

Engine Biosciences is a venture-backed San Francisco- and Asia-based technology company pioneering network biomedicine. Our proprietary and patented technologies oriented around deciphering the complexity of biology networks include both high-throughput wet lab experimentation and artificial intelligence algorithms for drug discovery and cellular reprogramming. This platform, developed through several years of research by our scientific founding and leadership team who include faculty members at MIT, Harvard, Mayo Clinic, and UCSD, dramatically accelerates and reduces costs of the R&D process for new medical therapies.  We are actively applying the platform internally and with partners across a range of disease indications.

In January 2018, we announced the closing of a US$10M seed round from notable biotech and tech institutional investors and are expanding the team.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $27M

    Engine Biosciences has raised a total of $27M of funding over 5 rounds. Their latest funding round was raised on Oct 31, 2023 in the amount of $27M.

  • $10M$25M

    Engine Biosciences's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $27M

    Engine Biosciences has raised a total of $27M of funding over 5 rounds. Their latest funding round was raised on Oct 31, 2023 in the amount of $27M.

  • $10M$25M

    Engine Biosciences's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.